Biomerica (BMRA) Shares Outstanding (2010 - 2026)
Biomerica (BMRA) posted Shares Outstanding (Entity) of $3.0 million for Q1 2026, up 2.76% sequentially from $2.9 million in Q4 2025, and up 19.0% YoY from $2.5 million in Q1 2025.
Biomerica (BMRA) Shares Outstanding (2010 - 2026) Analysis & Trends
Biomerica has reported Shares Outstanding (Entity) for 17 years, with the latest figure at $3.0 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 19.0% year-over-year to $3.0 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $3.0 million (up 19.0% YoY) and the FY2025 annual result came in at $2.5 million, up 21.09% from the prior year.
- Shares Outstanding (Entity) advanced to $3.0 million in Q1 2026 per BMRA's latest filing, from $2.9 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $3.0 million in Q1 2026 and troughed at $1.6 million in Q1 2022.
- A 5-year average of $2.2 million and a median of $2.1 million in 2023 frame the typical range for Shares Outstanding (Entity).
- The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Entity) changed 0.0% in 2024, then jumped 33.89% in 2025.
- Over 5 years, Shares Outstanding (Entity) stood at $1.7 million in 2022, then rose by 24.8% to $2.1 million in 2023, then grew by 9.01% to $2.3 million in 2024, then grew by 28.61% to $2.9 million in 2025, then climbed by 2.76% to $3.0 million in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $3.0 million, $2.9 million, and $2.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 | 3.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 3.01 Mn |
| Nov 30, 2025 | 2.91 Mn |
| Aug 31, 2025 | 2.64 Mn |
| May 31, 2025 | 2.30 Mn |
| Feb 28, 2025 | 2.40 Mn |
| Nov 30, 2024 | 2.14 Mn |
| Aug 31, 2024 | 2.10 Mn |
| May 31, 2024 | 2.10 Mn |
| Feb 29, 2024 | 2.10 Mn |
| Nov 30, 2023 | 2.10 Mn |
| Aug 31, 2023 | 2.10 Mn |
| May 31, 2023 | 1.77 Mn |
| Feb 28, 2023 | 1.69 Mn |
| Nov 30, 2022 | 1.68 Mn |
| Aug 31, 2022 | 1.64 Mn |
| May 31, 2022 | 1.58 Mn |
| Feb 28, 2022 | 1.60 Mn |
| Nov 30, 2021 | 1.57 Mn |
| Aug 31, 2021 | 1.55 Mn |
| May 31, 2021 | 1.49 Mn |